Literature DB >> 26747886

White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy.

Andreas Charidimou1, Gregoire Boulouis1, Kellen Haley1, Eitan Auriel1, Ellis S van Etten1, Panagiotis Fotiadis1, Yael Reijmer1, Alison Ayres1, Anastasia Vashkevich1, Zora Y Dipucchio1, Kristin M Schwab1, Sergi Martinez-Ramirez1, Jonathan Rosand1, Anand Viswanathan1, Steven M Greenberg1, M Edip Gurol2.   

Abstract

OBJECTIVE: To identify different white matter hyperintensity (WMH) patterns between 2 hemorrhage-prone cerebral small vessel diseases (SVD): cerebral amyloid angiopathy (CAA) and hypertensive arteriopathy (HA).
METHODS: Consecutive patients with SVD-related intracerebral hemorrhage (ICH) from a single-center prospective cohort were analyzed. Four predefined subcortical WMH patterns were compared between the CAA and HA groups. These WMH patterns were (1) multiple subcortical spots; (2) peri-basal ganglia (BG); (3) large posterior subcortical patches; and (4) anterior subcortical patches. Their associations with other imaging (cerebral microbleeds [CMBs], enlarged perivascular spaces [EPVS]) and clinical markers of SVD were investigated using multivariable logistic regression.
RESULTS: The cohort included 319 patients with CAA and 137 patients with HA. Multiple subcortical spots prevalence was higher in the CAA compared to the HA group (29.8% vs 16.8%; p = 0.004). Peri-BG WMH pattern was more common in the HA- vs the CAA-ICH group (19% vs 7.8%; p = 0.001). In multivariable logistic regression, presence of multiple subcortical spots was associated with lobar CMBs (odds ratio [OR] 1.23; 95% confidence interval [CI] 1.01-1.50, p = 0.039) and high degree of centrum semiovale EPVS (OR 2.43; 95% CI 1.56-3.80, p < 0.0001). By contrast, age (OR 1.05; 95% CI 1.02-1.09, p = 0.002), deep CMBs (OR 2.46; 95% CI 1.44-4.20, p = 0.001), total WMH volume (OR 1.02; 95% CI 1.01-1.04, p = 0.002), and high BG EPVS degree (OR 8.81; 95% CI 3.37-23.02, p < 0.0001) were predictors of peri-BG WMH pattern.
CONCLUSION: Different patterns of subcortical leukoaraiosis visually identified on MRI might provide insights into the dominant underlying microangiopathy type as well as mechanisms of tissue injury in patients with ICH.
© 2016 American Academy of Neurology.

Entities:  

Mesh:

Year:  2016        PMID: 26747886      PMCID: PMC4753727          DOI: 10.1212/WNL.0000000000002362

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  31 in total

1.  Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy.

Authors:  Andrew Dumas; Gregory A Dierksen; M Edip Gurol; Amy Halpin; Sergi Martinez-Ramirez; Kristin Schwab; Jonathan Rosand; Anand Viswanathan; David H Salat; Jonathan R Polimeni; Steven M Greenberg
Journal:  Ann Neurol       Date:  2012-07       Impact factor: 10.422

2.  White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy?

Authors:  Andreas Charidimou; Zane Jaunmuktane; Jean-Claude Baron; Matthew Burnell; Pascale Varlet; Andre Peeters; John Xuereb; Rolf Jäger; Sebastian Brandner; David J Werring
Journal:  Neurology       Date:  2013-11-27       Impact factor: 9.910

3.  Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.

Authors:  M Edip Gurol; Anand Viswanathan; Christopher Gidicsin; Trey Hedden; Sergi Martinez-Ramirez; Andrew Dumas; Anastasia Vashkevich; Alison M Ayres; Eitan Auriel; Ellis van Etten; Alex Becker; Jeremy Carmasin; Kristin Schwab; Jonathan Rosand; Keith A Johnson; Steven M Greenberg
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

4.  Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy.

Authors:  Andreas Charidimou; Rolf Hans Jäger; Zoe Fox; Andre Peeters; Yves Vandermeeren; Patrice Laloux; Jean-Claude Baron; David John Werring
Journal:  Neurology       Date:  2013-07-17       Impact factor: 9.910

5.  Topography of dilated perivascular spaces in subjects from a memory clinic cohort.

Authors:  Sergi Martinez-Ramirez; Octavio Marques Pontes-Neto; Andrew P Dumas; Eitan Auriel; Amy Halpin; Megan Quimby; Mahmut Edip Gurol; Steven M Greenberg; Anand Viswanathan
Journal:  Neurology       Date:  2013-04-03       Impact factor: 9.910

6.  Incidence of symptomatic hemorrhage in patients with lobar microbleeds.

Authors:  Ellis S van Etten; Eitan Auriel; Kellen E Haley; Alison M Ayres; Anastasia Vashkevich; Kristin M Schwab; Jonathan Rosand; Anand Viswanathan; Steven M Greenberg; M Edip Gurol
Journal:  Stroke       Date:  2014-06-19       Impact factor: 7.914

7.  Characteristic distributions of intracerebral hemorrhage-associated diffusion-weighted lesions.

Authors:  Eitan Auriel; Mahmut Edip Gurol; Alison Ayres; Andrew P Dumas; Kristin M Schwab; Anastasia Vashkevich; Sergi Martinez-Ramirez; Jonathan Rosand; Anand Viswanathan; Steven M Greenberg
Journal:  Neurology       Date:  2012-11-28       Impact factor: 9.910

8.  Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage: a multicentre MRI cohort study.

Authors:  Andreas Charidimou; Rukshan Meegahage; Zoe Fox; Andre Peeters; Yves Vandermeeren; Patrice Laloux; Jean-Claude Baron; Hans Rolf Jäger; David J Werring
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-02-14       Impact factor: 10.154

Review 9.  Outcome markers for clinical trials in cerebral amyloid angiopathy.

Authors:  Steven M Greenberg; Rustam Al-Shahi Salman; Geert Jan Biessels; Mark van Buchem; Charlotte Cordonnier; Jin-Moo Lee; Joan Montaner; Julie A Schneider; Eric E Smith; Meike Vernooij; David J Werring
Journal:  Lancet Neurol       Date:  2014-02-27       Impact factor: 44.182

10.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.

Authors:  Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

View more
  49 in total

Review 1.  Neuropsychological Effects of Cerebral Amyloid Angiopathy.

Authors:  Matthew Schrag; Howard Kirshner
Journal:  Curr Neurol Neurosci Rep       Date:  2016-08       Impact factor: 5.081

2.  Different Strokes: A management dilemma.

Authors:  Arunodaya R Gujjar; Mortada El-Tigani; Darshan Lal; Anupam K Kakaria; Abdullah R Al-Asmi
Journal:  Sultan Qaboos Univ Med J       Date:  2018-09-09

3.  Intracranial Hemorrhage Risk in the Era of Antithrombotic Therapies for Ischemic Stroke.

Authors:  Jesse M Thon; M Edip Gurol
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-05

Review 4.  Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk.

Authors:  M Edip Gurol
Journal:  Stroke       Date:  2017-12-04       Impact factor: 7.914

Review 5.  Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria.

Authors:  Steven M Greenberg; Andreas Charidimou
Journal:  Stroke       Date:  2018-01-15       Impact factor: 7.914

6.  White matter hyperintensities: relationship to amyloid and tau burden.

Authors:  Jonathan Graff-Radford; Eider M Arenaza-Urquijo; David S Knopman; Christopher G Schwarz; Robert D Brown; Alejandro A Rabinstein; Jeffrey L Gunter; Matthew L Senjem; Scott A Przybelski; Timothy Lesnick; Chadwick Ward; Michelle M Mielke; Val J Lowe; Ronald C Petersen; Walter K Kremers; Kejal Kantarci; Clifford R Jack; Prashanthi Vemuri
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

7.  Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage.

Authors:  Gregoire Boulouis; Andreas Charidimou; Michael J Jessel; Li Xiong; Duangnapa Roongpiboonsopit; Panagiotis Fotiadis; Marco Pasi; Alison Ayres; M Emily Merrill; Kristin M Schwab; Jonathan Rosand; M Edip Gurol; Steven M Greenberg; Anand Viswanathan
Journal:  Neurology       Date:  2017-01-27       Impact factor: 9.910

8.  Hemorrhage recurrence risk factors in cerebral amyloid angiopathy: Comparative analysis of the overall small vessel disease severity score versus individual neuroimaging markers.

Authors:  Gregoire Boulouis; Andreas Charidimou; Marco Pasi; Duangnapa Roongpiboonsopit; Li Xiong; Eitan Auriel; Ellis S van Etten; Sergi Martinez-Ramirez; Alison Ayres; Anastasia Vashkevich; Kristin M Schwab; Jonathan Rosand; Joshua N Goldstein; M Edip Gurol; Steven M Greenberg; Anand Viswanathan
Journal:  J Neurol Sci       Date:  2017-07-09       Impact factor: 3.181

9.  Primary Intracerebral Hemorrhage: A Closer Look at Hypertension and Cerebral Amyloid Angiopathy.

Authors:  David Roh; Chung-Huan Sun; J Michael Schmidt; Edip Gurol; Santosh Murthy; Soojin Park; Sachin Agarwal; E Sander Connolly; Jan Claassen
Journal:  Neurocrit Care       Date:  2018-08       Impact factor: 3.210

Review 10.  Vascular Cognitive Impairment.

Authors:  Jonathan Graff-Radford
Journal:  Continuum (Minneap Minn)       Date:  2019-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.